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Summary
Introduction: Articular cartilage matrix synthesis and degradation are dynamic processes that must be balanced for proper maintenance of the
tissue. In osteoarthritis (OA), this balance is skewed toward degradation and ultimate loss of matrix. The transcriptional and/or activity levels of
hundreds of genes are dysregulated in chondrocytes from osteoarthritic cartilage, and a subset of these genes may represent pivotal factors
that could be modulated if their speciﬁc role in the disease process could be identiﬁed.
Objective: To investigate the role of ADAMTS-4 and ADAMTS-5 in cartilage matrix degradation by developing a chondrocyte pellet culture
assay in combination with adenoviral gene expression, and to demonstrate the utility of this assay by assessing the speciﬁc functional
contribution of these genes to cartilage matrix metabolism.
Methods: A full-length cDNA for bovine ADAMTS-4 (bADAMTS-4) was isolated, and used to evaluate the expression, regulation, and activity
of this gene in bovine cartilage. Adenoviruses expressing bADAMTS-4, human ADAMTS-5 (hADAMTS-5) or human bone morphogenetic
protein 2 (BMP-2) were used to infect primary chondrocytes, and their effect on extracellular matrix metabolism was assessed by monitoring
the accumulation and release of glycosaminoglycans (GAG) in three-dimensional chondrocyte pellet cultures.
Results: Analysis of bADAMTS-4 transcriptional regulation in chondrocytes revealed that interleukin-1a (IL-1a) was the most potent inducer of
bADAMTS-4 mRNA and subsequent aggrecan degradation in cartilage explant cultures of those cytokines tested. bADAMTS-4 mRNA
induction by IL-1a was greater in nasal cartilage than in articular cartilage. Chondrocytes infected with adenovirus expressing either
bADAMTS-4 or hADAMTS-5 genes showed increased aggrecan degradation in newly synthesized matrix by pellet cultures while
chondrocytes overexpressing BMP-2 showed increased aggrecan synthesis.
Conclusion: Adenoviral delivery of genes to primary bovine chondrocytes, followed by culture in three-dimensional pellet format and
evaluation of extracellular matrix protein metabolism, is a useful functional assay for assessing the role of genes on cartilage matrix synthesis
and degradation.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Bovine aggrecanase, ADAMTS-4, ADAMTS-5, Adenoviral gene transfer, Chondrocyte pellet culture.
International
Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA) is the most common form of progressive
arthritic disease, affecting up to 190 million people
worldwide1 and up to 20 million individuals in the United
States. More than 50% of people over 65 years of age and
about 80% of those over age 75 have radiographic
evidence of this disease2. The precise etiology of OA is
yet to be discovered but the general clinical observation is
the degradation of cartilage matrix components due to
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Received 11 January 2004; accepted 3 May 2004.599predominating expression and activation of degradative pro-
teinases, such as matrix metalloproteinases (MMPs) and
aggrecanases. Although OA is generally deﬁned as a non-
inﬂammatory form of arthritis, proinﬂammatory cytokines
such as interleukin-1 (IL-1) and tumor necrosis factor (TNF)-a
have been implicated as important mediators of this dis-
ease3e5. In response to IL-1 and TNFa, chondrocytes
upregulate the synthesis, secretion and activation of cata-
bolic factors that are manifested in increased rates of
proteoglycan (PG) and collagen degradation.
Aggrecanases are metalloproteinases belonging to the
ADAMTS family and are responsible for the physiological
cleavage of aggrecan at speciﬁc GlueXaa peptide bonds6,7
resulting in aggrecan release from articular cartilage into the
synovial ﬂuid in both normal and osteoarthritic joints8,9.
Aggrecan is an abundant cartilage PG that, combined with
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that are essential characteristics of articular cartilage func-
tion. An early event in OA is the degradation of cartilage
aggrecan by cleavage of the core protein at (among other
sites in the aggrecan molecule) a critical point between the
G1 and G2 amino-terminal domains, in the so-called inter-
globular domain (IGD). Aggrecan can be cleaved in the IGD
at the Asn341ePhe342 bond in vitro by MMPs7,10e13,
Cathepsin B (at low pH)14, and ADAMTS-415 but N-terminal
sequencing of aggrecan fragments puriﬁed from the syno-
vial ﬂuid of OA patients has shown that the predominant
in vivo cleavage of aggrecan occurs at the Glu373eAla374
bond in the aggrecan IGD9,13 and deﬁnes OA-related
aggrecanase activity. This aggrecanase proteolytic activity
results in the release of the functionally important glycos-
aminoglycan (GAG)-rich aggrecan C-terminus from the
hyaluronic acid (HA)-bound G1 domain and concomitant
loss of the large C-terminal domain from the extracellular
matrix.
Two proteases that are capable of cleaving cartilage
aggrecan efﬁciently in vitro at the critical Glu373eAla374
bond have been cloned, and named aggrecanase-1 and
aggrecanase-216,17. Both proteases are structurally related,
as they are both metalloproteinases belonging to the ‘‘A
Disintegrin And Metalloproteinase with Thrombospondin
motifs’’ (ADAMTS) family and therefore they are called
ADAMTS-4 (aggrecanase-1) and ADAMTS-5/11 (aggreca-
nase-2). As such, ADAMTS-4 and ADAMTS-5 are pro-
duced as pro-metalloproteinases with an amino-terminal
secretory leader peptide followed by a pro-peptide domain,
a zinc metalloproteinase domain, a disintegrin-like domain,
and one (ADAMTS-4) or two (ADAMTS-5) thrombospondin
type 1 motifs. Since the initial cloning of these two enzymes,
signiﬁcant effort by many investigators has been devoted to
determining if ADAMTS-4 and/or ADAMTS-5 are the
enzyme(s) responsible for cartilage catabolism in OA. The
results of these studies have provided evidence that
ADAMTS-4 and/or ADAMTS-5 may be responsible for
cytokine-mediated aggrecan degradation in vitro. For in-
stance, both recombinant ADAMTS-4 and ADAMTS-5 are
reported to cleave aggrecan at four preferred sites between
the G2 and G3 domains (Glu1480eGly1481, Glu1667e
Gly1668, Glu1771eAla1772, Glu1871eLeu1872) in addition to
the Glu373eAla374 IGD cleavage18,19. This same pattern of
aggrecan cleavage has been seen in either interleukin-1a
(IL-1a)- or tumor necrosis factor a (TNFa)-stimulated
articular cartilage explant cultures20. It has been reported
that ADAMTS-4 transcription is upregulated in response to
IL-1a or TNFa in cultured adult bovine chondrocytes, while
ADAMTS-5 mRNA is not21. Inhibitor studies in cytokine-
treated cartilage explant cultures have also suggested the
relative importance of aggrecanase(s); compounds that
inhibit aggrecanases preferentially over MMP’s are capable
of inhibiting aggrecanase activity in in vitro and in vivo
assays22. Finally, immunodepletion of ADAMTS-4 and
ADAMTS-5 from the culture media of IL-1a-induced
cartilage explants substantially reduced aggrecan catabolic
activity when the antibody-treated culture supernatants
were subsequently tested for aggrecanase activity using
puriﬁed aggrecan as the substrate21. Taken together, these
data suggest that ADAMTS-4 and/or ADAMTS-5 may be
the relevant aggrecan-degrading proteases that are syn-
thesized by articular chondrocytes in response to IL-1a and
TNFa. To date, however, direct evidence of the ability of
each of these aggrecanases to degrade aggrecan within
a cell-derived or native cartilage matrix or in vivo has not
been shown. Thus all published studies in this area arecorrelative only and conclusions have been based upon the
relationship between the abundance of the aggrecanases
(mRNA and/or protein) and the rate of aggrecanase-
mediated degradation.
In this study, we describe a culture system for primary
chondrocytes that permits introduction of expression
vectors and subsequent monitoring of extracellular matrix
synthesis and degradation while maintaining a chondrocytic
phenotype. We report the isolation of a full-length cDNA for
bovine ADAMTS-4 (bADAMTS-4) and, using an adenovirus
gene delivery and expression methodology, we show that
expression of either bADAMTS-4 or human ADAMTS-5
(hADAMTS-5) in primary bovine chondrocytes results in
markedly increased degradation of endogenous aggrecan
synthesized by the chondrocytes in pellet culture.
Materials and methods
CARTILAGE EXPLANT ISOLATION AND CULTURE
Cartilage was obtained from the metacarpophalangeal
joint of calves (2e10 days old) or of adult cows, and nasal
cartilage was obtained from calf nasal septum. Mature
articular cartilage explants (1 mm thick disks) were pre-
pared as described previously23 and cultured while stirring
for 72 h at 37(C in a humidiﬁed atmosphere (5% CO2/95%
air) in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
containing 5% fetal bovine serum (FBS), 10 mM HEPES,
50 mg/ml L-ascorbic acid, 100 U/ml penicillin and 100 mg/ml
streptomycin for equilibration. Calf explants were prepared
from the top 1 mm of the articular surface (w3 mm thick) of
epiphyseal cartilage. For 35S incorporation studies to
assess PG synthesis and release, the disks were labeled
by the addition of 35SO4 (10 mCi/ml, NEN, Boston, MA) to
the culture media for another 72 h followed by two washes
with media containing no radioactive sulfate over 24 h.
Explants were then cultured in 48 well plates, 1e2 disks per
well, and conditioned media were collected daily. Cartilage
explants were digested with proteinase K for 35S de-
termination of PG remaining in the explant.
RNA PREPARATION
Bovine articular and nasal cartilage were obtained as
described above and cultured for 3e4 days in DMEM
supplemented with 5% FBS, penicillin (100 U/ml) and
streptomycin (100 mg/ml). Cartilage pieces were snap
frozen in liquid nitrogen and pulverized using a Spex
Certiprep freezer mill Model 6750 at 15 Hz twice for 1 min
each. The frozen powdered cartilage was immediately
suspended in 4 M guanidinium isothiocyanate (GITC)
(Gibco-BRL, Carlsbad, CA) containing 8.9 mM 2-mercap-
toethanol (bME) and homogenized at 4(C with a Polytron
homogenizer at maximum speed setting twice for 1 min
each time. The homogenate was centrifuged at 1500!g for
10 min and the supernatant was saved. The pellet was
resuspended in GITC/bME and homogenized a second
time as described above. The two resulting supernatant
fractions were combined and incubated with Triton X-100
(2% ﬁnal concentration) and sodium acetate ( pH 5.5, 1.5 M
ﬁnal concentration) sequentially for 15 min each. The
samples were extracted once with an equal volume of acid
phenol chloroform ( pH 4.5) and twice with acid phenol ( pH
4.5)/phenol ( pH 7.5) chloroform mix (1:1). RNA was
subsequently precipitated with isopropanol, and further
puriﬁed using an RNeasy Mini kit (QIAGEN, Valencia,
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density A260/A280 and Agilent RNA6000 assay (Palo Alto,
CA). No pulverization was required to prepare RNA from
chondrocyte pellets. Pellets were digested with collagenase
(2.5 mg/ml, Sigma, St Louis, MO) and RNA was sub-
sequently prepared using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s recommen-
dation.
Bovine calf (2e10 days old) lung, kidney, brain (cerebel-
lum), testis, small intestine, skeletal muscle, heart, liver and
spleen were obtained fresh from a local slaughterhouse
(Research 87, MA) and total RNA fromw0.5e1 gm tissues
was isolated using TRIzol. For RNA isolation from cultured
chondrocytes, TRIzol reagent was added directly to the
culture plate following phosphate buffered saline (PBS)
wash of the cells and cellular RNA was isolated as
described by TRIzol’s manufacturer. For TaqMan analysis
(ABI PRISM 7700 sequence detection, Perkin Elmer,
Boston, MA), the total RNA was further puriﬁed with two
more rounds of phenol/chloroform extraction followed by
RNeasy column binding and elution. To ensure the elimina-
tion of genomic DNA, RNA was treated with DNase
(QIAGEN) once during RNeasy column puriﬁcation (as
recommended by the supplier) and again following the RNA
puriﬁcation using DNA-free (Ambion, Austin, TX), following
the manufacturer’s instructions.
PRIMARY CHONDROCYTE ISOLATION AND CULTURE
Full-thickness epiphyseal cartilage slices were dissected
under aseptic conditions, rinsed 4 times in PBS, and
subjected to collagenase digestion [0.023% Collagenase
1A (Sigma, St Louis, MO), 126 mg/ml DNase (Sigma),
0.62 mg/ml hyaluronidase (Sigma)] overnight at 37(C to
isolate chondrocytes embedded in the cartilage matrix24.
The digest was ﬁltered through 125 mm nylon mesh (Small
Parts Co., Miami Lakes, FL) and washed twice in DME
containing 10% FBS. Typically 0:5e1!108 cells were
obtained from a single calf metacarpophalangeal joint
surface. Cells were plated in monolayer in six well plates
at a density of 2!106 cells=well. For pellet culture, cells were
resuspended in growth media (DME, penicillin (50 IU/ml)/
streptomycin (50 mg/ml), 2 mM glutamine, 50 mg/ml ascor-
bate and 10% FBS) at 1!106 cells=ml and aliquoted 1 ml
per tube in 15 ml Falcon centrifuge tubes as described
previously25. The cells were centrifuged at 200!g for 5 min
at 4(C and the resulting cell pellets were cultured initially in
media containing 10% FBS. Conditioned media were
collected and replaced (3 ml/well, 1 ml/tube) with media
containing decreasing concentration of FBS (5%, 2.5%,
then 0%) every 3e4 days for the ﬁrst 10 days to wean
chondrocytes from the serum. Pellets were then maintained
in serum-free media for an additional 11 days. At the end of
the culture period, pellets were harvested and either
digested with 0.5 ml 300 mg/ml papain at 65(C for 3e6 h
for dimethylmethylene blue (DMMB) assays or prepared for
histology (see below).
CLONING OF BOVINE ADAMTS-4
Total RNA obtained from IL-1a stimulated bovine articular
cartilage was used as a source of bADAMTS-4 mRNA. RT-
PCR was performed (RETROscript, Ambion, Austin, TX
and GeneAmp, Applied Biosystems, NJ) with this RNA as
described previously using the oligonucleotide primers
previously reported26 to isolate a cDNA fragment encodingthe catalytic region of bADAMTS-4 including the zinc-
binding motif and most of the disintegrin-like domain.
Sequences speciﬁc for bADAMTS-4 were then used to
design PCR primers to enable extension of the known
sequence to isolate the entire coding sequence. The
SMART RACE methodology (Clontech, Palo Alto, CA) for
rapid ampliﬁcation of cDNA ends (RACE) was employed,
using the following primers: 3# RACE (6Agg1fZ
5#-GCTCCTGTGATGGCTCACGTGGAT-3#, 8Agg1fZ 5#-
CGCACTGACCTCTTCAAGAACTTCC-3#) and 5# RACE
(12Agg1rZ 5#-CCCATTCAGACCAGTGCATTGCTTCGA
G-3#). First-strand cDNA was synthesized using reverse
transcriptase and an oligo-dT primer, with RNA isolated
from IL-1a-treated bovine primary articular chondrocytes.
The ﬁrst-strand cDNA was adapted on the 5# ( for 3# RACE)
or 3# ( for 5# RACE) ends with a SMART primer (Clontech)
to provide a terminal priming site. Nested positive (C) strand
bADAMTS-4 speciﬁc primers were used to amplify the
unknown 3# coding sequence in combination with a univer-
sal primer that anneals to the sequence of the oligo-dT
primer. The 5# coding sequence of bADAMTS-4 was
ampliﬁed using nested negative () strand bADAMTS-4
speciﬁc primers in combination with a universal 5# primer
that anneals to the SMART primer tail.
PCR products resulting from the 5# and 3# RACE
reactions were subcloned into the pCRII-TOPO TA cloning
vector (Invitrogen, Carlsbad, CA) and sequenced. The
resulting DNA sequences were used to design bADAMTS-
4-speciﬁc PCR primers ( f2Agg1f: 5#-GGGCCAAGTTT-
TCTCCAACTCC-3#, f2Agg1r: 5#-TCCTACCCTTGACTCT-
TCCTTTCCGAG-3#) to enable ampliﬁcation of a full-length
bADAMTS-4 cDNA clone by RT-PCR (RETROscript for RT
and Advantage 2 PCR kit, Clontech, Palo Alto, CA) with
cycling conditions of 95(C for 30 s followed by 68(C for
3 min for 30 cycles. The resulting PCR product encompass-
ing the entire coding sequence for bADAMTS-4 was
subcloned into pCRII-TOPO and multiple isolates were
sequenced on both strands to conﬁrm the correct
sequence.
NORTHERN BLOT
Total RNA (12e15 mg), isolated from bovine calf cartilage
explant cultures or bovine tissues, was resolved by
electrophoresis in a denaturing formaldehyde/agarose
(1%) slab gel and transferred to Gene-Screen Plus nylon
membrane (NEN) by capillary blotting. RNA (28S and 18S)
was visualized by ethidium bromide staining of the gel to
ensure equal loading of the samples. A 716 bp bADAMTS-4
(corresponding to amino acids 309e539 in Fig. 1) and
a 540 bp bADAMTS-5 PCR product ampliﬁed using the
primers previously used by Curtis et al.26 were labeled by
random hexamer priming using 32P-dCTP (Ready To Go
Beads, Amersham, Piscataway, NJ). The labeled DNA was
puriﬁed using a Sephadex G-50 NICK Column (Pharmacia).
The blot was hybridized overnight at 42(C in NorthernMax
hybridization buffer (Ambion, Austin, TX) following 2e4 h
prehybridization in the same buffer. The blot was washed
as recommended in the NorthernMax literature, and
exposed to Kodak Biomax MS ﬁlm with an intensifying
screen at 80(C.
ADENOVIRAL VECTOR CONSTRUCTION
The vectors used to produce adenovirus for this study
were replication-defective human adenovirus type 5 with
MSHMDSHPGR GLADGWLWGI QPRLLLPTVP VSGSRLVWLL LLASLLPSAW PASPLPREEE IVFPEKLNG- SVLPGLGAPA RLLYRLPAFG 90
MSQTGSHPGR GLAGRWLWGA QPCLLLPIVP LSWLVWLLLL LLASLLPSAR LASPLPREEE IVFPEKLNG- SVLPGSGTPA RLLCRLQAFG
MSQMGLHPRR GLTGHWLQRF QPCLPLHTV- ----QWRRLL LLAFLLSLAW PASPLPREEE IVFPEKLNGS SILPGSGVPA RLLYRLPAFG
ETLLLELEKD PGVQVEGLTV QYLGRAPELL GGAEPGTYLT GTINGDPESV ASLHWDGGAL LGVLQYRGTE LHIQPLEGGA PNSAGGPGAH 180
ETLLLELEQD SGVQVEGLTV QYLGQAPELL GGAEPGTYLT GTINGDPESV ASLHWDGGAL LGVLQYRGAE LHLQPLEGGT PNSAGGPGAH
EMLLLELEQD PGVQVEGLTV QYLGQAPEML GGAEPGTYLT GTINGDPESV ASLHWDGGAL LGVLQYRGAE LHLQPLEGGA LNSAGGPGAH
ILRRKSPVSG QGPMCNVKAP PGKPSPSPRR AKRFASLSRF VETLVVADDK MAAFHGAGLK RYLLTVMAAA AKAFKHPSIR NPVSLVVTRL 270
ILRRKSPASG QGPMCNVKAP LGSPSPRPRR AKRFASLSRF VETLVVADDK MAAFHGAGLK RYLLTVMAAA AKAFKHPSIR NPVSLVVTRL
ILRRKSPASS QGPMCTVKAP SGSPSPISRR TKRFASLSRF VETLVVADDK MAAFHGTGLK RYLLTVMAAA AKAFKHPSIR NPVNLVVTRL
---------- ---------- --------RR TKRFASLSRF VETLVVADDK MAAFHGAGLK HYLLTVMAAA AKAFKHPSIR NPVNLVVTRL
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
.......... .......... ........RR .KRFASLSRF VETLVVADDK MAAFHG.GLK .YLLTVMAAA AKAFKHPSIR NPV.LVVTRL
VVLGPGEEGP QVGPSAAQTL RSFCAWQRGL NTPDDADPGH FDTAILFTRQ DLCGVSTCDT LGMADVGTVC DPARSCAIVE DDGLQSAFTA 360
VILGSGEEGP QVGPSAAQTL RSFCAWQRGL NTPEDSDPDH FDTAILFTRQ DLCGVSTCDT LGMADVGTVC DPARSCAIVE DDGLQSAFTA
VILGSGQEGP QVGPSAAQTL RSFCTWQRGL NTPNDSDPDH FDTAILFTRQ DLCGVSTCDT LGMADVGTVC DPARSCAIVE DDGLQSAFTA
VILGSGQEVP QVGPSAAQTL RSFCTWQKGL NPPNDSDPDH FDTAILFTRQ DLCGVSTCDA LGMAGVGTVC DPARSCAIVE DDGLQSAFTA
---------- ---------- ---------- ---------- ---------- ---------- --MADVGTVC DPARSCAIVE DDGLQSAFTA
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
V.LG.G.E.P QVGPSAAQTL RSFC.WQ.GL N.P.D.DP.H FDTAILFTRQ DLCGVSTCD. LGMADVGTVC DPARSCAIVE DDGLQSAFTA
AHELGHVFSM LHDNSKQCTG LNGPESTSRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG FGHCLLDKPE APLHLPVTFP GKDYDADRQC 450
AHELGHVFNM LHDNSKPCIS LNGPLSTSRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG YGHCLLDKPE APLHLPVTFP GKDYDADRQC
AHELGHVFNM LHDNSKPCTN LNGQGGSSRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG YGHCLLDKPE APLHLPATFP GKDYDADRQC
AHELGHVFNM LHDNSKPCAN LNGQGSSSRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG YGHCLLDKPE APLHLPVTFP GKDYDADRQC
AHELGHVFNM LHDNSKPCVG LNGPGSTSRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG YGHCLLDKPE APLHLPVTFP GKDYDADRQC
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
AHELGHVFNM LHDNSKPC.. LNG..S.SRH VMAPVMAHVD PEEPWSPCSA RFITDFLDNG YGHCLLDKPE APLHLPVTFP GKDYDADRQC
QLTFGPDSRH CPQLPPPCAA LWCSGHLNGH AMCQTKHSPW ADGTPCGPAQ ACMGGRCLHV DQLQAFNVPQ AGGWGPWGSW GDCSRSCGGG 540
QLTFGPDSRH CPQLPPPCAA LWCSGHLNGH AMCQTKHSPW ADGTPCGPAQ ACMGGRCLHM DQLQDFNIPQ AGGWGPWGPW GDCSRTCGGG
QLTFGPDSSH CPQLPPPCAA LWCSGHLNGH AMCQTKHSPW ADGTPCGSSQ ACMGGRCLHV DQLKDFNVPQ AGGWGPWGPW GDCSRTCGGG
QLTFGPDSSH CPQLPPPCAA LWCFGHLNGH AMCQTKHSPW ADGTPCGPAQ ACMGGRCLHV DQLKDFNIPQ AGGWGPWGPW GDCSRTCGGG
QLTFGPDSRH CPQLPPPCAA LWCSGHLNGH AMCQTKHSPW ADGTPCGPAQ ACMGGRCLHM DQLQEFNIPQ AGGW------ ----------
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
QLTFGPDS.H CPQLPPPCAA LWCSGHLNGH AMCQTKHSPW ADGTPCGPAQ ACMGGRCLH. DQL..FN.PQ AGGWGPWG.W GDCSR.CGGG
VQFSSRDCTR PVPRNGGKYC EGRRTRFRSC NTQDCPTGSA LTFREEQCAA YNHRTDLFKN FPGPMDWVPR YTGVAPRDQC KLTCQTRALG 630
VQFSSRDCTR PVPRNGGKYC EGRRTRFRSC NTEDCPTGSA LTFREEQCAA YNHRTDLFKS FPGPMDWVPR YTGVAPQDQC KLTCQARALG
VQFSSRDCTR PVPRNGGKYC EGRRTRFRSC NTENCPHGSA LTFREEQCAA YNHRTDLFKS FPGPMDWVPR YTGVAPRDQC KLTCQARALG
VQFSSRDCTK PVPRNGGKYC EGRRTPFRSC NTKNCPHGSA LTFREEQCAA YNHRTDLFKS FPGPMDWVPR YTGVAPRDQC KLTCQARALG
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
------DCTR PVPRNGGKYC EGRRTRFRSC NTENCPHGSA LTFREEQCAA YNHRTDLFKS FPGPMDWVPR YTGVAPRDQC KLTCQARALG
VQFSSRDCTR PVPRNGGKYC EGRRTRFRSC NT..CP.GSA LTFREEQCAA YNHRTDLFKS FPGPMDWVPR YTGVAPRDQC KLTCQARALG
A Signal sequence Pro-
Metalloproteinase
Disintegrin-like
Tsp
Spacer
YYYVLDPRVA DGTPCSPDSS SVCVQGRCIH AGCDRVIGSK KKFDKCMVCG GDGSSCSKQS GSFKKFRYGY NNVVTIPAGA THILVRQQGS 720
YYYVLEPRVV DGTPCSPDSS SVCVQGRCIH AGCDRIIGSK KKFDKCMVCG GDGSGCSKQS GSFRKFRYGY NNVVTIPAGA THILVRQQGN
YYYVLEPRVA DGTPCSPDTS SVCVQGRCIH AGCDRIIGSK KKFDKCMVCG GDGSRCSKQS GSFKKFRYGY SDVVTIPAGA THILVRQQGG
YYYVLEPRVA DGTPCSPDSS SVCVQGRCIH AGCDRIIGSK KKFDKCMVCG GNGSSCSKQS GSFKKFRYGY SDVVTIPAGR THILVRQQGG
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
YYYVLEPRVA DGTPCSPDTS S--------- ---------- ---------- ---------- ---------- ---------- ----------
YYYVLEPRVA DGTPCSPD.S SVCVQGRCIH AGCDR.IGSK KKFDKCMVCG G.GS.CSKQS GSF.KFRYGY ..VVTIPAG. THILVRQQG.
PSVRSLYLAL KLPDGSYALN GEYTLIPSPT DVVLPGAVSL RYSGATAASE TLSGHGPLAE PLTLQVLVAG NPQNARLRYS FFVPRPRPVP 810
PGHRSIYLAL KLPDGSYALN GEYTLMPSPT DVVLPGAVSL RYSGATAASE TLSGHGPLAQ PLTLQVLVAG NPQDTRLRYS FFVPRPTP--
SGLKSIYLAL KLSDGSYALN GEYTLMPSPT DVVLPGAVSL RYSGATAASE TLSGHGPLAQ PLTLQVLVAG NPQNARLRYS FFVPRPVP--
SGLKSIYLAL KLADGSYALN GEYTLMPSST DVVLPGAVSL RYSGRTAASE TLSGHGPLAQ PLTLQVLVAG NPQNVRLRYS FFVPRPVP--
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
....S.YLAL KL.DGSYALN GEYTL.PS.T DVVLPGAVSL RYSG.TAASE TLSGHGPLA. PLTLQVLVAG NPQ..RLRYS FFVPRP.P--
STPRPTPQDW LRRKSQILEI LRRRSWAGRK
STPRPTPQDW LHRRAQILEI LRRRPWAGRK
STPRPPPQDW LQRRAEILKI LRKRPWAGRK
STPRPPPQNW LQRRAEILEI LRKRTWAGRK
---------- ---------- ----------
---------- ---------- ----------
STPRP.PQ.W L.R...IL.I LR.R.WAGRK
SS Pro Catalytic Dis Tsp SPACER
(716bp)
(540bp)
Agg-1
B
Agg-2
Fig. 1. (A) Comparison of the protein sequence of bovine ADAMTS-4 (bADAMTS-4) with published ADAMTS-4 sequences from other species.
Amino acid sequence deduced from the cloned bADAMTS-4 cDNA is shown and underlined. Consensus sequences among all the published
ADAMTS-4 sequences [hZhuman, mZmouse, rZrat, equZhorse ( partial) and orycZrabbit ( partial)] are shown as bold letters. Protein
domains are labeled above the sequences and are delineated by arrows. Preprosequences (signal sequence and pro-) are followed by highly
conserved catalytic (metalloproteinase) domain, disintegrin-like domain, thrombospondin motifs (Tsp), and spacer regions. Conserved zinc-
binding motifs of metalloproteinases are boxed by a dashed line. The nucleotide sequence of this bovine ADAMTS-4 (aggrecanase-1) was
deposited in GenBank (accession number AF516915). (B) ADAMTS-4/5 domain structure. Locations and lengths of cDNA probes used for
Northern blots are indicated by black bars.
603Osteoarthritis and Cartilage Vol. 12, No. 8complete deletion of the E1a and E1b regions and partial
deletion of the E3 region of the viral genome. Vectors
containing the cDNAs encoding bADAMTS-4, hADAMTS-
517 and bone morphogenetic protein 2 (BMP-2)27, each
under the control of the cytomegalovirus (CMV) promoter,
were used to propagate recombinant viruses in human
embryonic kidney (HEK293) cells (ATCC, Manassas, VA).
The virus stocks were then puriﬁed by two rounds of cesium
chloride centrifugation27. The puriﬁed viruses were dialyzed
in PBS and stored at 80(C in 10% glycerol in PBS at
a concentration of 109 pfu/ml. A similar adenoviral vector
containing the green ﬂuorescent protein gene (AdGFP) was
used as a control.
VIRAL INFECTION OF CHONDROCYTES
For monolayer chondrocyte cultures, chondrocytes were
infected 24 h post-plating and for pellet cultures, cells were
infected immediately following isolation and prior to pellet-
ing. Cells were cultured in a minimal volume (1 ml per well
for six well plates, 0.5 ml per tube for 15 ml Falcon tubes) of
growth media containing 2% FBS prior to the addition of
adenovirus. Adenovirus expressing GFP, BMP-2, bA-
DAMTS-4, or hADAMTS-5 was added directly into the
culture at a multiplicity of infection (MOI) of 5000 (or as
otherwise indicated) and swirled. Growth media (see
above) containing 10% FBS were added to the culture
after 2-h incubation at 37(C (in an humidiﬁed atmosphere
of 5% CO2). For pellet cultures, the serum concentration
was gradually decreased every 3 days to 5%, 2.5% and
ﬁnally to 0% (serum-free) with every feeding of the
chondrocyte pellets.
PRODUCTION OF MONOCLONAL ANTIBODY, AGG-C1
The synthetic peptide CGGPLPRNITEGE-COOH (pep-
tide aggc1) was coupled to the carrier protein KLH, and the
conjugate was used as the immunogen for the production of
monoclonal antibodies by standard hybridoma technology.
Brieﬂy, BALB/c mice were immunized subcutaneously with
20 mg of immunogen in complete Freund’s adjuvant. The
injection was repeated twice (biweekly) using peptide in
incomplete Freund’s adjuvant. Test bleeds were done on
the immunized mice, and serum was evaluated by ELISA
for reactivity against both the immunizing peptide and
ADAMTS-4-digested bovine articular cartilage aggrecan28.
Three days prior to hybridoma fusion, a ﬁnal immunization
without adjuvant was given to the mouse exhibiting highest
antibody titer. Spleen cells from this mouse were isolated
and fused with FO myeloma cells (American Type Culture
Collection, Manassas, VA) and cultured in HAT selection
medium (SigmaeAldrich, St Louis, MO). Hybridoma culture
supernatants were screened against KLH and KLH-
CGGPLPRNITEGE antigens by ELISA, and against
ADAMTS-4-digested aggrecan by Western blotting. Posi-
tive hybridoma clones were selected for subcloning by
limiting dilution. A single hybridoma cell line, designated
AGG-C1, was expanded in culture. Antibody isotype was
determined to be IgG1 (k light chain) using the Mouse
Monoclonal Antibody Isotyping kit (Roche, Indianapolis, IN)
and IgG from 1 l of culture media was puriﬁed by Protein A
afﬁnity chromatography.
SDS/PAGE AND IMMUNOBLOTTING
Serum-free conditioned media (after weaning from
serum, day 12 and day 19) from pellet cultures wereharvested and centrifuged at 2000!g for 10 min at 4(C to
remove non-adherent cells. The remaining pellets were
washed 3 times in cold PBS, incubated for 5 min on ice in
NP40 lysis buffer (1% NP40, 150 mM NaCl, 0.05% SDS,
50 mM Tris) containing 1 mg/ml soybean trypsin inhibitor
(Sigma), and centrifuged at 12; 000!g for 10 min at 4(C.
Samples (40 ml of 1 ml sample) were resolved by 12%
SDS-polyacrylamide gel electrophoresis under reducing
conditions and transferred to a nitrocellulose membrane
(Hybond C, Amersham) by electroblotting. Non-speciﬁc
binding was blocked by 5% non-fat dry milk in Tris buffered
saline (TBS)/0.1% Tween for 1 h at room temperature. The
blot was washed for 15 min in TBS/0.3% Tween followed
by two 5 min washes in TBS/0.1% Tween. The blot was
then probed with rabbit anti-human ADAMTS-4 polyclonal
antibody L902628 (Wyeth, Cambridge, MA) diluted 1:1000
in TBS/0.1% Tween for a 1.5 h incubation followed by a
15 min wash with TBS/0.3% Tween and two 5 min washes
with TBS/0.1% Tween. The blot was then incubated for 1 h
with an anti-rabbit HRP antibody (Amersham, Piscataway,
NJ) diluted 1:10,000 in TBS/0.1% Tween. The protein was
visualized by ECL detection (Amersham) following the
manufacturer’s instructions.
For the detection of aggrecan cleavage sites using
neoepitope monoclonal antibodies Agg-C1 or AF-28
(Chemicon International Inc., Temecula, CA) (anti-
342FFGVG, detects MMP cleavage site), samples approx-
imately equivalent to 20 mg of PG (measured by DMMB
assay) were deglycosylated with chondroitinase ABC and
keratinase and separated by 4e12% Novex Triseglycine
gels (Invitrogen, Carlsbad, CA). Subsequently, the samples
were electrophoretically transferred to nitrocellulose and
immunoreactive products were detected.
MORPHOLOGIC AND HISTOLOGIC ANALYSES
Cultured chondrocyte pellets were harvested, washed
once in PBS and frozen on dry ice in OCT compound
(Sakura Finetek, Torrance, CA). Fresh frozen sections
(10 mm) of pellets were thawed and ﬁxed in 4% para-
formaldehyde for 5 min. The sections were stained with
Fast Green FCF (Sigma, St Louis, MO) and Safranin O
(Polyscientiﬁc, Bay Shore, NY) to visualize the GAG
remaining within the pellets by light microscopy.
GAG ASSAY AND HYDROXYPROLINE ASSAY
The level of sulphated GAG in the culture media and
cartilage/pellet extracts was determined by the DMMB
assay, as described by Farndale et al.29. Shark and whale
chondroitin sulfate (Fluka Biochemika, Switzerland) was
used as a standard. The collagen content in the pellet
extract was measured using the hydroxyproline assay
originally introduced by Stegemann and Stalder30 following
modiﬁcation described by Reddy and Enwemeka31.
QUANTITATION OF DNA IN CHONDROCYTE PELLETS
Chondrocyte pellets were washed in PBS and digested
with papain (300 mg/ml) for 3e5 h. DNA content in each
pellet (mg/tube) was measured using Hoechst dye 33258
(Polysciences, Warrington, PA) according to the methods
previously described32.
TAQMAN ANALYSIS
Oligonucleotide primers and ﬂuorescently-labeled Taq-
Man probes for bovine aggrecanase and GAPDH cDNA
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software (Applied Biosystems, Warrington, UK). Sequences
for primers and probes were as follows: bADAMTS-4
forward: 5#-TGTGTGGTGGGGATGGTT-3#, reverse 5#-
GCACCAGGATGTGGGTG-3#, probe 5#-FAM-CTGGCT-
CCTTCAAAAAATTCAGGTACGGA-TAMRA-3#; bADAMT-
S-5 forward 5#-ATTTCGGCTCCACGGAAGAT-3#, reverse
5#-TTCTGTGATGGTGGCTGAGG-3#, probe 5#-FAM- ATT-
GACGCATCCAAACCCTGGTCCA-TAMRA-3#; bGAPDH
forward: 5#-AAAGTGGACATCGTCGCCAT-3#, reverse 5#-
GACTGTGCCGTTGAACTTGC-3#, probe 5#-FAM-TTCAC-
TACATGGTCTACATGTTCCAGTATGATTCCA-TAMRA-3#.
TaqMan PCR analysis was performed using the Applied
Biosystems ABI Prism 7700 sequence detection system.
PCR reactions for all samples were performed in duplicate
(20 ng DNase-treated puriﬁed total RNA) using TaqMan
One Step PCR master mix reagent kit (Applied Biosystems)
following the manufacturer’s protocol. Thermocycler con-
ditions comprised an initial reverse transcription step with
incubation at 48(C for 30 min, followed by AmpliTaq Gold
enzyme activation at 95(C for 10 min, and ﬁnally PCR
ampliﬁcation performed at 95(C for 15 s, 60(C for 1 min for
40 cycles. Threshold cycle (CT) values were obtained for
ADAMTS-4 and ADAMTS-5 and the values were divided by
CT values for GAPDH to obtain the relative expression level
of aggrecanases normalized to GAPDH expression.
Results
SEQUENCE OF BOVINE ADAMTS-4 AND COMPARISON WITH
ADAMTS-4 PROTEINS FROM OTHER SPECIES
Only partial sequence for bADAMTS-4 has been pre-
viously reported26. The partial bADAMTS-4 sequence was
used to design bADAMTS-4-speciﬁc PCR primers that were
used in combination with RACE primers speciﬁc for the
terminal sequences of the ﬁrst-strand cDNA synthesized
using SMART RACE technology (see Materials and
methods). The resulting PCR products, representing novel
5# and 3# coding sequence of bADAMTS-4, were subcl-
oned and DNA sequencing was performed on the inserts.
The resulting sequence was used to design exact PCRprimers to amplify the entire intact bADAMTS-4 cDNA from
the same RNA source. We deposited the nucleotide
sequence for bADAMTS-4 in GenBank (accession number
AF516915).
The amino acid sequence derived from the bADAMTS-4
cDNA is shown underlined in Fig. 1, compared to published
ADAMTS-4 orthologues. There is a high degree of
conservation of amino acid sequence throughout the
protein when compared to ADAMTS-4 protein sequences
from other species. Overall, bADAMTS-4 is 92% identical to
hADAMTS-4, with the catalytic domains sharing the highest
degree of homology (95% identical). The overall domain
structure is preserved among all species. The domain with
the least sequence similarity between bADAMTS-4 and
hADAMTS-4 is the signal sequence (33% identical),
reﬂecting a conservation of function over primary sequence
that is frequently seen among inter-species gene homologs.
EXPRESSION AND REGULATION OF BOVINE ADAMTS-4 IN
ARTICULAR CARTILAGE
The expression and inducibility of ADAMTS-4 in articular
cartilage by cytokines has previously been reported21. In
this study we compared ADAMTS-4 mRNA upregulation by
several proinﬂammatory cytokines: IL-1a, IL-1b and TNFa.
IL-1a was the most potent stimulator of ADAMTS-4
expression and subsequent PG breakdown in bovine calf
cartilage [Fig. 2(A), lane 2 and (B)]. Upregulation of
ADAMTS-4 mRNA persisted throughout the 48 h time
period [Fig. 2(A), lanes 6e7]. Signiﬁcant IL-1a-induced PG
release in explant culture media was detected within the
ﬁrst 24 h and peaked at 48 h whereas PG degradation
stimulated by TNFa was slower; the highest level of TNFa-
mediated increase in PG release was detected at 72 h from
the initiation of incubation (data not shown). The induction
of ADAMTS-4 mRNA by IL-1a was evaluated in adult and
calf articular cartilage as well as in nasal cartilage by both
Northern blot hybridization [Fig. 3(A)] and TaqMan analysis
[Fig. 3(B)]. These data indicated that IL-1a stimulated
ADAMTS-4 mRNA levels in both articular and nasal
cartilage, but induction was signiﬁcantly higher in nasal
cartilage compared to that of articular cartilage [Fig. 3(A),Fig. 2. Cytokine-induced upregulation of bADAMTS-4 mRNA in bovine cartilage explant culture shown by Northern blot (A) and subsequent
increase in aggrecan breakdown (B). (A) Cartilage explants isolated from 2 to 14 day old calves were cultured for 3 days, labeled with 35SO4
for 72 h and washed extensively for 24 h to remove unincorporated 35S. Subsequently, the explants were incubated with or without cytokines
(lane 1Znone, lane 2Z10 ng/ml IL-1a, lane 3Z10 ng/ml IL-1b, lane 4Z100 ng/ml TNFa) for 24 h and RNA prepared as described in
Materials and methods. Lanes 5e7 show IL-1a stimulated bADAMTS-4 mRNA expression at time 0 (lane 5), 24 h (lane 6) and 48 h (lane 7).
Lower panel shows the gel stained with ethidium bromide to allow estimation of RNA loading. (B) At the end of 24 h incubation with cytokines,
conditioned media were collected, explants were digested with proteinase K (20 mg/ml) and 35S in media was compared to total 35S count and
expressed as % GAG release.
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ADAMTS-4 mRNA were also signiﬁcantly higher in adult
than in young articular cartilage [Fig. 3(B), P!0:05]
suggesting that older cartilage may be more susceptible
to cytokine-mediated aggrecan catabolism. IL-1a upregula-
tion of ADAMTS-5 mRNA in calf articular cartilage was
similar to that of ADAMTS-4 [Fig. 4(A), lanes 1 and 2].
Northern blots of calf articular and nasal cartilage probed
with an ADAMTS-5 cDNA showed that nasal cartilage
expressed higher levels of ADAMTS-5 mRNA upon IL-1a
treatment than did articular cartilage [Fig. 4(A), lanes 2 and
4]. Concomitant with IL-1a-mediated increase in ADAMTS-
4 and ADAMTS-5 mRNA levels, analysis of GAG degrada-
tion in these same cartilage explant cultures showed
a substantial increase in GAG release upon addition of IL-
1a [Fig. 4(B)]. Articular cartilage displayed a higher basal
level of GAG release than nasal cartilage but IL-1a
Fig. 3. Analysis of ADAMTS-4 mRNA levels in articular and nasal
cartilage treated with IL-1a. (A) Northern blot of juvenile and adult
bovine cartilage with or without IL-1a stimulation. Total RNA was
isolated from unstimulated bovine cartilage, and from bovine
cartilage stimulated by IL-1a (10 ng/ml) for 24 h. Upper panel:
12 mg of total RNA was loaded and probed with a bovine ADAMTS-
4 probe and the ﬁlm was exposed for 24 h. Lower panel shows the
gel stained with ethidium bromide to allow estimation of RNA
loading. (B) TaqMan RT-PCR analysis of ADAMTS-4 levels in
bovine cartilage. DNase-treated cartilage RNA (as described in
Materials and methods) was subjected to TaqMan analysis for
bovine ADAMTS-4. CT values for the samples were normalized to
CT values for GAPDH as indicated in Materials and methods. Each
bar represents the mean and standard deviation (SD) of four
TaqMan reactions.induction of GAG release was greater in nasal cartilage
(w9 fold) than in articular cartilage (w5 fold). Although
nasal cartilage expressed higher levels of ADAMTS-4 and
ADAMTS-5 than articular cartilage upon IL-1a induction, the
percentage of GAG released was comparable between the
two types of cartilage [Fig. 4(B)].
EXPRESSION ANALYSIS OF AGGRECANASES IN BOVINE CALF
TISSUES
To characterize tissue distribution of ADAMTS-4 and
ADAMTS-5 expression, total RNA was isolated from brain,
liver, lung, kidney, muscle, heart, spleen, intestine and
testis of 2e10 day old calves. Northern analysis of these
RNA’s using cDNA probes from bADAMTS-4 and
ADAMTS-5 showed high level expression of these tran-
scripts only in IL-1a-induced cartilage samples [Fig. 5(A),
lanes 1 and 2, and (C), lanes 1 and 2] which served as
a positive control for this Northern blot. ADAMTS-4
expression was almost undetectable by Northern blot in
all of the tissues studied [Fig. 5(A)] including uninduced
cartilage [Fig. 5(A), lane 1]. This tissue distribution of
bADAMTS-4 mRNA differed signiﬁcantly from that reported
for hADAMTS-4 by Abbaszade et al., who demonstrated
high mRNA levels in lung and moderate expression in brain,
Fig. 4. Upregulation of ADAMTS-5 mRNA expression and aggrecan
degradation upon treatment with IL-1a. IL-1a (10 ng/ml) was added
to calf articular or nasal cartilage explants 24 h prior to harvesting
media and cells for GAG release assays and RNA isolation. (A)
Northern blot of bADAMTS-5 expression by IL-1a treated cartilage
explants. Equal amounts (12 mg) of total RNA isolated from articular
or nasal cartilage was loaded onto a denaturing formaldehyde/
agarose gel and the blot was probed with the 32P-labeled
bADAMTS-5 cDNA probe indicated in Fig. 1(B). The panel on the
left is an autoradiogram from a 96-h exposure of the Northern blot.
The panel on the right shows the RNA gel stained with ethidium
bromide to show the relative amount of RNA loaded in each lane.
(B) GAG released into conditioned media was measured by
scintillation counting of incorporated 35SO4. The amount of GAG
released to the conditioned media is expressed relative to the
amount remaining in the explant as the % GAG released over 24 h.
Each bar represents the mean and SD of triplicate wells.
606 M. Arai et al.: ADAMTS-4/5 overexpression in chondrocytesFig. 5. Distribution of ADAMTS-4 (A, B) and ADAMTS-5 (C, D) mRNA expression in bovine tissues. For Northern blots (A, C), non-treated
(lane 1) and IL-1a treated (10 ng/ml, lane 2) nasal cartilage RNA (10 mg) were loaded as controls, 15 mg of total RNA was loaded for the other
tissues (lane 3, brain/cerebellum; lane 4, liver; lane 5, lung; lane 6, kidney; lane 7, skeletal muscle; lane 8, heart; lane 9, spleen; lane 10, small
intestine; lane 11, large intestine; lane 12, testis). Expression of ADAMTS-4 (B) and ADAMTS-5 (D) mRNA was also evaluated by TaqMan
RT-PCR analysis. Bars representing each sample tissue are aligned in the same order as the Northern blots above, and the levels of
ADAMTS-4/5 expression normalized to GAPDH expression are shown by the bar graphs. (E) Ethidium bromide staining of the gel used for the
Northern blot, serving as a loading control and providing 28S and 18S size markers.heart and skeletal muscle16. Therefore, the tissue distribu-
tion patterns of bADAMTS-4/5 expression were re-investi-
gated using a more sensitive TaqMan PCR analysis.
TaqMan results [Fig. 5(B, D)] correlated well with those
from the Northern analyses [Fig. 5(A, C)]. Low levels of
ADAMTS-4 expression were seen in brain and lung, where
ADAMTS-5 expression was generally more readily
detectable. Higher levels of ADAMTS-5 expression were
seen in liver, lung, kidney and spleen, with moderate levels
detected in intestine and testis. On the whole, ADAMTS-4
and ADAMTS-5 mRNA expression were dramatically in-
creased upon IL-1a stimulation in nasal cartilage but low in
all of the unstimulated tissues studied, including cartilage.
These results demonstrate potentially signiﬁcant species
and/or age differences in the expression patterns of
ADAMTS-4 and ADAMTS-5.OPTIMIZATION OF ADENOVIRALLY MEDIATED GENE EXPRESSION
IN CHONDROCYTES
Articular chondrocytes are very difﬁcult to transfect
efﬁciently using lipid-mediated gene transfer methods.
Maximal transfection efﬁciency of only 30e40% has been
achieved33 (and our unpublished observation). Therefore,
we have used adenovirus-mediated gene delivery to
overexpress ADAMTS-4 and ADAMTS-5 in primary articu-
lar chondrocytes. Observation of AdGFP-infected bovine
primary chondrocytes by ﬂuorescence microscopy showed
85e90% infection efﬁciency with an MOI of 1000, which
appeared saturating as judged by GFP ﬂuorescence
[Fig. 6(A)]. However, the PG degrading effect of bovine
AdADAMTS-4 was not evident in chondrocytes infected
with an MOI of 1000. AdADAMTS-4 infection at 5000 MOI
607Osteoarthritis and Cartilage Vol. 12, No. 8Fig. 6. Optimization of adenoviral infection of bovine chondrocytes using AdGFP (A) and dose response effect of AdADAMTS-4 on
proteoglycan degradation (B). (A) Fluorescence microscopy of chondrocytes in monolayer culture infected with varying MOI of AdGFP.
Saturation of % infection (w90%) was reached at 1000e5000 MOI. No cell death was observed even with highest MOI tested. (B) Dose effect
of adenovirus expressing ADAMTS-4 on GAG release in pellet cultures. GAG accumulation in culture media between day 14 and day 18 post-
infection in pellet culture was measured by DMMB assay. Each bar represents the mean and SD of three pellet samples.was required to obtain a signiﬁcant increase in GAG release
in the culture media [Fig. 6(B)]. Therefore our subsequent
experiments were performed with chondrocytes infected
with 5000 MOI adenovirus. In order to verify the over-
expression of ADAMTS-4 protein resulting from adenovirus
expressing ADAMTS-4, Western blot analysis was per-
formed using rabbit anti-human polyclonal ADAMTS-4
antibody [Fig. 7]. An w80 kDa band likely representing
pro-ADAMTS-4 (retaining its pro-peptide) was present only
in the cell extract, while 63 and 53 kDa bands which
presumably represent mature and c-terminally cleaved
secreted forms of ADAMTS-4, respectively (which would
correspond to human are 68 and 53 kDa), were evident
mostly in the conditioned media collected at day 12 and day
19 post-infection. Earlier time points were not collected for
Western analysis due to the presence of serum in the
culture media.
PELLET CULTURE AND THE EFFECT OF AGGRECANASE
OVEREXPRESSION IN PG METABOLISM
Chondrocytes in vivo are embedded in an extracellular
matrix, and when articular chondrocytes are isolated
and maintained in monolayer culture their biosyntheticphenotype changes from chondrogenic to ﬁbroblast-like.
This process is known as dedifferentiation. Many investiga-
tors have reported three-dimensional culture systems such
as agarose or alginate bead cultures34,35 that prevent such
dedifferentiation of primary chondrocytes. More recently,
a number of investigators have utilized pellet culture as
a three-dimensional culture system25,36 and showed
increased matrix synthesis by this method due to high cell
numbers in a pellet. Uninfected primary chondrocytes in
pellet culture produced w200e400 mg of PG in a pellet
containing 1!106 chondrocytes after 21 days in culture
[Figs. 8(A) and 9(B)]. Type II collagen (conﬁrmed by
Western blot analysis using anti-type II collagen antibodies,
data not shown) was also produced by primary chondro-
cytes in pellet culture to levels that were easily detectable
and monitored within 14 days, and continued to accumulate
during 28 days of culture [Fig. 8(B)]. After 3 months in
culture, primary chondrocyte pellets approximated cartilage
explants in size [Fig. 8(C), and data not shown].
GAG content of pellet cultures was signiﬁcantly increased
when an anabolic factor such as BMP-2 was overexpressed
in the chondrocytes via AdBMP-2 infection [Fig. 9(B, C)], as
evidenced by increased pellet size. Excessive aggrecan
synthesis in these pellets mediated by adenovirus-mediated
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of the pellet and resulted in increased GAG content in the
media [Fig. 9(A, B)]. Conversely, overexpression of both
bADAMTS-4 and hADAMTS-5 in pelleted chondrocytes
stimulated aggrecan breakdown and release into the media
throughout the time course of the culture [Fig. 9(A)],
resulting in signiﬁcant reduction in pellet size [Fig. 9(C)]
and pellet GAG content [Fig. 9(B)] at the end of 21 days of
culture. The GAG released to the media as a result of
AdADAMTS-4 or AdADAMTS-5 infection of chondrocytes in
pellet culture was analyzed by Western blotting with
neoepitope antibodies capable of detecting aggrecan
cleavage at the Glu373eAla374 bond [Agg-C1 antibody,
Fig. 9(D), left panel] or at the Asn341ePhe342 bond [AF-28
antibody, Fig. 9(D), right panel] in the aggrecan IGD.
Expression of either of the aggrecanases (ADAMTS-4 or
ADAMTS-5) resulted in cleavage at the aggrecanase-
sensitive Glu373eAla374 bond of aggrecan [Fig. 9(D)] while
infection of chondrocyte pellet cultures with an adenovirus
expressing human MMP-13 resulted in substantial pellet
aggrecan cleavage at the Asn341ePhe342 bond without
detectable cleavage of the Glu373eAla374 bond [Fig. 9(D)].
In addition, MMP-13 expression in chondrocyte pellets
resulted in substantial collagen cleavage and total loss of
integrity of the pellet (data not shown). Therefore, matrix
components secreted by primary chondrocytes in pellet
cultures serve as reliable indicators of the enzymatic
activities of both catabolic and anabolic factors expressed
by the cells.
Infection of chondrocytes with a high MOI of adenovirus
(e.g., AdGFP) did not appear to cause detectable levels of
cell death as judged by cellular DNA content [Fig. 9(E)]. In
contrast, expression of catabolic enzymes (AdADAMTS-4
and AdADAMTS-5) caused a detectable decrease in DNA
content compared to that of uninfected and AdGFP-infected
pellets [Fig. 9(E)], indicating a decrease in cell number after
21 days in culture. However, it appears that the decrease in
pellet sizes seen in Fig. 9(C) for AdADAMTS-4 and
AdADAMTS-5 resulted from increased proteolysis and not
from decreased cell viability, since the total amount of GAG
(media+pellet) synthesized by pellets expressing the
catabolic enzymes equaled or even exceeded that of the
controls [Fig. 9(A, B)].
Fig. 7. Expression of ADAMTS-4 protein in primary chondrocytes
using adenovirus. Western blot analysis with anti-ADAMTS-4
polyclonal antisera on culture media (CM) and cell extract (CE) of
adenovirus (expressing ADAMTS-4) infected chondrocytes (+) and
uninfected () chondrocytes. Chondrocytes were infected with
5000 MOI of AdADAMTS-4 prior to culturing for 12 (d12) or 19 (d19)
days in pellet form (1!106 cell=pellet). Positive control, C, is con-
ditioned media from a CHO cell line stably expressing carboxyl-
terminally truncated (active) human ADAMTS-4 ( p53). Molecular
weight size markers migrated as depicted to the left of the ﬁgure.Signiﬁcant loss of PG in the chondrocyte pellet matrix of
ADAMTS-4 and ADAMTS-5 infected samples was also
evident by Safranin O staining of pellet sections [Fig. 10(c,
d]. Pellets expressing GFP retained Safranin O positive
matrix [Fig. 10(b)] and are indistinguishable from uninfected
pellets [Fig. 10(a)]. Similar loss of PG (decreased Safranin
O staining) was also observed in uninfected chondrocyte
pellets stimulated by addition of 1 ng/ml of IL-1a to the
culture media [Fig. 9(H)] indicating comparable matrix
degradation between IL-1 treated and aggrecanase over-
expressing chondrocyte pellets. TaqMan quantitative PCR
analysis of RNA from primary chondrocyte pellet cultures
treated with IL-1a and TNFa using bADAMTS-4 and
ADAMTS-5 probe/primer sets showed that both ADAMTS-
4 and ADAMTS-5 mRNA were upregulated in pellet
chondrocytes after 24 h incubation with IL-1a and TNFa
[Fig. 11(A, B), respectively]. Increased GAG release was
detected in the culture media over the same 24 h incubation
with the cytokines [Fig. 11(C)]. Hence, primary chondrocyte
pellet cultures respond to IL-1a and TNFa in a comparable
manner to chondrocytes in explant cultures [Figs. 2, 3(B)
and 4(B)].
Fig. 8. Time course of extracellular matrix formation by chondrocyte
pellets. Increase in pellet size over 4 weeks of culture correlated well
with the increase in proteoglycan (A) and collagen content (B).
Pellets containing 1!106 chondrocytes were digested with papain
on the days indicated after the start of the culture and the
proteoglycan (GAG) and collagen content in the pellets were
determined by DMMB and hydroxyproline assays, respectively.
Matrix deposition slowed after 1 month in culture; however,
continued culture resulted in pellets approaching the size of cartilage
explants (6 mm diameter) atw3 months (C).
609Osteoarthritis and Cartilage Vol. 12, No. 8Fig. 9. Adenoviral expression of anabolic (AdBMP-2) and catabolic (AdADAMTS-4 and AdADAMTS-5) proteins in primary chondrocytes in
pellet culture signiﬁcantly affects extracellular matrix deposition and release. Chondrocytes were infected immediately after isolation with
adenoviruses expressing either bADAMTS-4 (bTS-4), hADAMTS-5 (hTS-5) or BMP-2, prior to centrifugation to create a pellet culture. (A)
Culture media were collected every 3e4 days and assayed for GAG release [aggrecan breakdown] by DMMB assays, and the cumulative
release of GAG in media over 2 weeks is shown. (B) Pellets from cultures in (A) were digested with papain on day 21 and GAG remaining in
the pellet was assayed by DMMB. (C) Photographic depiction of pellets of primary bovine chondrocytes infected with adenovirus expressing
BMP-2, bADAMTS-4 (bTS-4), or hADAMTS-5 (hTS-5) and cultured for 21 days in pellet culture. Scale at bottom is in millimeters. (D) Culture
media collected at day 12 were analyzed for aggrecan fragments containing N-terminal neoepitope NITEGE373 generated by aggrecanase
speciﬁc cleavage (left) or N-terminal neoepitope 242FFGVG generated by matrix metalloproteinase (MMP) (right) by Western blot analysis on
4e12% gels. (E) Similar experiment to (AeC) was repeated in parallel using adenovirus expressing GFP as a control and DNA content in
pellet digest (day 21) was assessed by Hoechst dye 33258 as an indicator of cellular toxicity.Discussion
Osteoarthritis has been historically deﬁned as a non-
inﬂammatory form of arthritis; however, synovial inﬂamma-
tion is clearly reﬂected in the signs and symptoms of OA37
and elevated levels of cytokines have been implicated as an
important mediator of the disease3e5,38. The proinﬂamma-
tory cytokines thus are likely to be major regulators of
downstream proteases (such as aggrecanases) that are
ultimately involved in matrix breakdown that results in
osteoarthritic lesions. Flannery et al.39 reported changes inthe activity but not mRNA level of aggrecanases (ADAMTS-
4/Agg-1 and ADAMTS-5/Agg-2) in response to IL-1a, TNFa
or retinoic acid (RA) stimulation using human articular
cartilage. Little or no change in ADAMTS-4 and ADAMTS-5
mRNA levels were observed in a comparison of normal to
osteoarthritic human cartilage40,41. These data suggested
that the changes in aggrecan matrix degradation in human
cartilage (e.g., OA) may not be caused by changes in
ADAMTS-4 and ADAMTS-5 transcription but rather by
changes in protein levels and/or their activity levels. In vitro,
610 M. Arai et al.: ADAMTS-4/5 overexpression in chondrocytesFig. 10. Chondrocytes expressing bADAMTS-4 or hADAMTS-5 signiﬁcantly deplete extracellular matrix proteoglycan levels. Bovine
chondrocyte pellets infected with adenovirus expressing ADAMTS-4 (c) or ADAMTS-5 (d) compared to no treatment (a) or GFP (b) adenovirus
infected control pellets after 1 week of culture, showing decreased level of Safranin O staining indicating loss of proteoglycan. Similar
histological characteristics were observed in pellet sections after 2 and 3 weeks (not shown). Sections eeh (10 mm) were prepared from non-
infected pellets stimulated by addition of increasing concentrations of IL-1a to the culture media for 1 week.cartilage and chondrocytes appear to behave differently.
For instance, ADAMTS-4 but not ADAMTS-5 mRNA was
reportedly upregulated by IL-1b in monolayer cultured
human chondrocytes40. We ﬁnd that the effect of cytokines
on ADAMTS-4 and ADAMTS-5 expression appears differ-
ent in the bovine system. In this study, we have
demonstrated the effect of different proinﬂammatory cyto-
kines on the expression of these aggrecanases and on PG
degradation both in calf cartilage explants and in three-
dimensional chondrocyte pellet cultures. We have seen
a signiﬁcant increase in ADAMTS-4 expression in response
to IL-1a in articular cartilage explants and an even greater
increase in nasal cartilage. Since articular and nasal
cartilage are derived from different embryologic origin,
direct comparison cannot be made; however, the signiﬁ-
cantly higher induction of aggrecanase transcripts by IL-1a
in nasal compared to articular cartilage without signiﬁcant
difference in GAG release between the two is interesting to
note. This disconnect maybe due to the following three
reasons; (1) 35SO4 incorporation into the cartilage and
subsequent release only account for newly synthesized
aggrecan cleavage and may not reﬂect the true aggrecandegradation event, (2) ADAMTS-4 message levels may not
reﬂect the amount of protein expressed, (3) there may be
a difference in activation of ADAMTS-4 in nasal vs articular
cartilage. Unlike human cartilage, calf cartilage expresses
higher basal levels of ADAMTS-4 mRNA compared to
ADAMTS-5. In this regard, our data appears to conﬂict with
a report that ADAMTS-5 mRNA is constitutively expressed
in adult bovine cartilage21. A signiﬁcant increase in
ADAMTS-4 mRNA in response to IL-1a was observed in
our study using calf cartilage and this induction was similar
to that reported for human chondrocytes40 and adult bovine
cartilage21. Little et al.42 reported a signiﬁcant increase
in both ADAMTS-4 and ADAMTS-5 mRNA in response to
IL-1a using calf cartilage explants, in agreement with our
data shown here. When chondrocytes isolated from the
same calf cartilage were plated in monolayer or pellet form,
they showed even greater upregulation of both ADAMTS-4
and ADAMTS-5 mRNA in response to cytokine stimulation.
It is interesting to note that it has been reported that
immortalized human chondrocytes increase the expression
of ADAMTS-5 but not ADAMTS-4 in response to IL-1a43.
Immunoﬂuorescence and Western blot analysis of
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shown constitutive protein expression with or without IL-1
stimulation44. These studies suggest that chondrocytes
may be sensitive to their surrounding environment and
change their transcriptional proﬁles and responsiveness
in vitro.
The time delay in the TNFa-mediated PG degradation in
bovine explants compared to IL-1a-induced GAG release
indicates that there may be a different mechanism involved
in the matrix degradation initiated by the two cytokines. If
ADAMTS-4 and ADAMTS-5 mRNA induction is also
delayed with TNFa stimulation compared to IL-1a, it may
suggest that the induction of ADAMTS-4 and ADAMTS-5 by
TNFa is indirect and may be mediated through induction of
IL-1a by TNFa. This possibility could be explored by
following IL-1 message levels after TNF stimulation or by
testing the ability of IL-1 antagonists (e.g., soluble IL-1
receptor antagonist or neutralizing antibodies to IL-1) to
block the effect of TNF. Alternatively, if there is no delay in
the induction of aggrecanase message by TNFa, this could
indicate a differential induction of a mediator of aggreca-
nase activation by IL-1a relative to TNFa.
The major impediment to studying cartilage biosynthesis
and degradation in vitro is the fact that articular chondro-
cytes dedifferentiate and change their biosynthetic proﬁle to
a ﬁbroblast-like phenotype within 1e2 week in monolayer
Fig. 11. Increase in ADAMTS-4 and ADAMTS-5 mRNA and
subsequent aggrecan degradation following 24 h stimulation of
pellets with IL-1a and TNFa. Chondrocytes obtained from 2 to 10
day old calves were cultured for 12 days in pellet form. Pellets were
cultured in growth media containing cytokines (0.1, 1 ng/ml of IL or
10 ng/ml TNF) on day 12 and media were collected 24 h later for
DMMB assay (C). Total RNA was prepared from the pellets as
described in Materials and methods and ADAMTS-4 (A) and
ADAMTS-5 (B) expression levels were quantitated by TaqMan
analysis and normalized to GAPDH expression levels.culture. Culturing chondrocytes in alginate beads to create
a three-dimensional conﬁguration is a commonly used
method that allows maintenance of a differentiated chon-
drocyte phenotype34. In our experience, this method re-
quires extra steps to polymerize and de-polymerize the
beads, and ﬁxing is required to study histological section of
the beads/matrix; moreover, the alginate interferes with the
DMMB assay. In this study we cultured chondrocytes in an
alternative three-dimensional system, pellet culture, origi-
nally described by Kato et al. in 198845. When isolated
bovine chondrocytes were cultured in pellet form and
allowed to synthesize new matrix, much lower concen-
trations of IL-1a were required to induce both ADAMTS-4
and ADAMTS-5 mRNA in contrast to those observed in
cartilage explant (unpublished observation). Although pellet
culture allows chondrocytes to keep their differentiated
phenotype and therefore continue to produce cartilagenous
matrix (both collagen and aggrecan) for 1e2 months, it is
important to note that the newly synthesized matrix contains
a signiﬁcantly higher number of chondrocytes than in vivo
cartilage matrix. A major advantage of this pellet cultured
chondrocyte technique over cartilage explants is that iso-
lated chondrocytes can be genetically manipulated to alter
the expression level of genes of interest prior to the for-
mation of extracellular matrix. The individual effects of genes
on matrix components can be then studied. Importantly,
evaluation of the activity of gene products can be performed
without prior expression and puriﬁcation of the protein. In
addition, the role of intracellular proteins (e.g., kinases,
phosphatases, etc.) on extracellular matrix synthesis and
degradation can be easily studied using this system.
In this report, we cloned full-length bovine aggrecanase-1
(bADAMTS-4) and utilized the cDNA to produce adenovirus
expressing functional bADAMTS-4. Since full-length hA-
DAMTS-4 and bADAMTS-4 sequences are highly
homologous (this study) and known partial sequence of
bADAMTS-5 possesses high homology to hADAMTS-5,
adenovirus expressing hADAMTS-5 was used instead of
bADAMTS-5 to test the effect of ADAMTS-5 on matrix
degradation. Adenoviral overexpression of an anabolic
protein, BMP-2, resulted in a dramatic increase in pellet
size over 3 weeks of culture, and the increase in aggrecan
content in the pellet was demonstrated by greater GAG
content in the pellet, and by histological evaluation. Over-
production of aggrecan caused by BMP-2 overexpression
also resulted in an increase in aggrecan monomers
detected in the culture media. This may have been caused
by a reduced capacity of the matrix for binding the aggrecan
monomers, a reduced capability of the newly synthesized
aggrecan to aggregate appropriately, and/or a concomitant
increase in aggrecan degradation mediated by BMP-2
activity. On the contrary, overexpression of both bADAMTS-
4 and hADAMTS-5 resulted in signiﬁcantly increased GAG
release into the culture media resulting in depletion of
aggrecan in the pellet matrix, conﬁrming the aggrecan-
cleaving function of these aggrecanases (individually) in
a semi-native environment. Depletion of Safranin O stain-
ing, indicative of the absence of PG in the matrix, was seen
in the pellet sections of chondrocytes overexpressing either
aggrecanase, and also in the pellet sections of chondro-
cytes treated with IL-1a in culture. In contrast to studies
showing increased GAG release by chondrocytes treated
with IL-1a or TNFa, which induces not only aggrecanases
but also other degradative enzymes, our studies show the
degradative effect of speciﬁc upregulation of ADAMTS-4
or ADAMTS-5 on aggrecan degradation in chondrocyte-
secreted matrix. These results support the possible
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induced cartilage matrix degradation. It is interesting to note
that the overexpression of MMP-13 (collagenase 3), an
MMP that is involved in degradation of both collagen and
aggrecan11 resulted in even smaller pellets with substantial
loss of structural integrity, clearly showing a difference in
phenotype from those pellets overexpressing ADAMTS-4
and ADAMTS-5 (unpublished observation). Overexpression
of either ADAMTS-4 or ADAMTS-5 resulted in a detectable
decrease in cellular DNA levels indicating either an increase
in cell death or a decrease in cell proliferation. This obser-
vation may suggest an additional role for these aggreca-
nase proteins in chondrocyte apoptosis. Further studies are
necessary to explore this aspect of aggrecanase function in
cellular metabolism.
Gene transfer in joints and cartilage is an extremely
difﬁcult procedure due to lack of vasculature and imperme-
ability of the cartilage matrix. Transformation of primary
chondrocytes with DNA vectors is notoriously inefﬁcient. Up
to 40% transfection efﬁciency using lipid-mediated gene
transfer to human articular chondrocytes has been re-
ported33. The highest efﬁciency of plasmid vector trans-
fection of these bovine primary chondrocytes that we
obtained was also about 35e40%, which was insufﬁcient
to study the effect of transfected genes with adequate
sensitivity. The effectiveness of adenovirus-mediated gene
transfer into chondrocytes has previously been demonstra-
ted46e48. Stimulation of chondrocyte extracellular matrix
synthesis by adenoviruses expressing insulin-like growth
factor I (IGF-1) or BMP-2 stimulated chondrocyte matrix
synthesis was reportedly effective only at low adenovirus
concentrations in monolayer rabbit chondrocytes47,48. In
this study, much higher MOI of adenovirus were required to
observe the effect; however, no cytotoxic effect of high MOI
was observed. The differences in the effective MOI could be
due to adenoviral species difference and/or the way the
virus was quantitated. Pellet culture allowed sufﬁcient
production of cartilage matrix from high-concentration
adenovirus infected chondrocytes for subsequent analysis
of anabolic or catabolic agents. GFP expression persisted
for at least 3 weeks after the infection of pellet chondrocytes
with adenovirus expressing GFP. In addition, newly synthe-
sized cartilage matrix of pellets is more permeable to
peptides and small molecule agents and therefore also
allows accurate measurement of the effects of these agents
on cartilage matrix synthesis (unpublished data).
In summary, chondrocytes in three-dimensional pellet
culture produce signiﬁcant amounts of extracellular matrix
over several weeks and even months in culture while
retaining their chondrocytic phenotype. Pellet culture of
chondrocytes allows manipulation of cells by either trans-
fection or infection, and quantiﬁcation of matrix production
inﬂuenced by the introduced gene. Adenovirus-mediated
overexpression of aggrecanases resulted in signiﬁcant loss
of aggrecan from the pellet matrix similar to that resulting
from cytokine stimulation.
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